What is EDSA (EDSA) stock price today?

EDSA (EDSA) is currently trading at $5.35, up 1.9% today.

What is EDSA P/E ratio?

EDSA's P/E ratio is -8.61. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is EDSA return on equity (ROE)?

EDSA's return on equity (ROE) is -58.33%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is EDSA's market cap?

EDSA has a market capitalization of $51.54M.

NASDAQ · Biotechnology

EDSA (EDSA) Stock

$5.35 +1.90% NASDAQ: EDSA Healthcare

Valuation

Metric	Value
Price	$5.35
Market Cap	$51.54M
P/E Ratio	-8.61
P/B Ratio	7.60
P/S Ratio	0.00
EPS (TTM)	$-1.27
52-Week High	$20.32
52-Week Low	$0.72
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-58.33%
ROA	-50.00%
ROCE	-61.54%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	12.00

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-24.0M	$-18.0M	$-9.0M	$-7.0M	$-8.0M
Net Profit	$-13.0M	$-18.0M	$-8.0M	$-6.0M	$-7.0M
EPS	$-7.73	$-8.37	$-2.93	$-1.93	$-1.27
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$15.0M	$12.0M	$9.0M	$4.0M	$14.0M
Total Liabilities	$2.0M	$2.0M	$2.0M	$2.0M	$1.0M
Cash	$8.0M	$7.0M	$5.0M	$1.0M	$11.0M
Borrowings	$0	$0	$0	$0	$0

Latest News

EDSA: Positive Exploratory Data in Patients with AKI Zacks Small Cap Research · Jul 2, 2026 Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors GlobeNewswire · Jun 11, 2026 Sector Update: Healthcare Stocks Gain Friday Afternoon MT Newswires · Jun 5, 2026 Top Midday Stories: Lululemon Down After Fiscal Q1 Results; Amazon Engineers Criticize AI Spending; Hoffman to Exit Microsoft Board MT Newswires · Jun 5, 2026 Edesa Biotech Says Paridiprubart Linked to Lower Risk of Death in Acute Kidney Injury Patients MT Newswires · Jun 5, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-14.0M	$-12.0M	$-7.0M	$-5.0M	$-7.0M
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$1.0M	$-1.0M	$-2.0M	$-4.0M	$10.0M
Free Cash Flow	$-14.0M	$-12.0M	$-7.0M	$-5.0M	$-7.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-8.39%
Quick Ratio	4.76
Interest Coverage	—
Return 1Y	207.11%
Return 3Y	15.23%
Return 5Y	-80.87%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$313.33	+0.29%	37.72	$4.60T	0.34%
MSFTMicrosoft Corporation	$499.99	+0.03%	22.95	$3.71T	0.94%
GOOGLAlphabet Inc.	$354.30	-0.96%	27.68	$4.29T	0.23%
AMZNAmazon.com, Inc.	$274.48	+0.82%	28.76	$2.95T	0.00%
METAMeta Platforms, Inc.	$592.10	+0.37%	21.47	$1.51T	0.35%

About EDSA

EDSA is led by CEO Pardeep Nijhawan, employs 16 people, headquartered in CA, publicly traded since 2010.

EDSA stock trades at $5.35 with a market capitalization of $51.54M. The stock is valued at a price-to-earnings (P/E) ratio of -8.61, price-to-book of 7.60, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.72 and $20.32, and currently trades 73.7% below its 52-week high.

On profitability, EDSA generates a return on equity (ROE) of -58.33%, return on capital employed of -61.54%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides